- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01551732
Anger Control Therapy (ACT) With RAGE-Control: An Outpatient Videogame-assisted Therapy for the Treatment of Anger
April 19, 2020 updated by: Gonzalez-Heydrich, Joseph, M.D.
The purpose of this study is to determine whether adding an interactive biofeedback video game to anger control cognitive behavioral therapy is an effective and feasible treatment.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Current treatments for pathological anger and aggression in youth are lacking in their effectiveness to motivate and engage patients in treatment.
As a result, mental health providers encounter challenges due to the limited generalizability of treatment effects to real-world situations outside of the therapist's office.
When behavioral treatments fail to show lasting results, children and adolescents are often placed on antipsychotic medication to control their behaviors, which may result in significant toxicity levels and for which there is limited knowledge of the long-term effects on pediatric growth and development.
This study tests an interactive biofeedback video game called RAGE-Control (for Regulate and Gain Emotional-Control) as a treatment for youth exhibiting anger and aggression.
Treatment with RAGE-Control seeks to motivate children and adolescents to learn and practice coping skills taught in therapy within the environment of a fun and enjoyable video game.
The game provides patients a venue to practice self-regulation techniques in response to the increasing stress of the game.
Providing patients with the opportunity to refine their self-regulation skills in a fast-paced challenging game is hypothesized to result in greater generalization of therapeutic skills to situations outside of the therapist's office.
The goal of the treatment is to decrease patients' feelings of anger, and to increase the patients' levels of control in their emotional and behavioral responses.
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02125
- Joseph Gonzalez-Heydrich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 13 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ages 10 to17 years old (inclusive).
- STAXI-CA score >15 on the Trait Anger subscales.
Exclusion Criteria:
- Inability to consent, comprehend, or effectively participate in the study.
- Cognitive impairment, defined as IQ < 75.
- Change in mood stabilizing and/or anti-psychotic medication dose within 4 weeks of beginning the study or anticipation of medication changes during the study period (10 weeks).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Anger Control Therapy
10 session manualized cognitive behavioral anger control therapy
|
10 session manualized cognitive behavioral anger control therapy
Other Names:
|
|
Experimental: ACT with RAGE-Control
10 session manualized cognitive behavioral anger control therapy augmented with an interactive biofeedback videogame.
|
10 session manualized cognitive behavioral anger control therapy augmented with interactive biofeedback videogame.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State Trait Anger Expression Inventory - Child and Adolescent
Time Frame: Baseline and two weeks Post treatment
|
This is a 35 item self-report measure of patients' subjective feelings of anger and aggression administered at the baseline assessment prior to the first session and again two weeks post treatment.
|
Baseline and two weeks Post treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disruptive Behavior Disorder Rating Scale (DBDRS)
Time Frame: Baseline and two weeks post treatment
|
This is an interview conducted by an investigator who is blinded to the patient's treatment assignment.
The investigator conducts this interview with the patient's parent/ guardian at baseline prior to the first session and again two weeks post treatment.
|
Baseline and two weeks post treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Joseph W Gonzalez-Heydrich, MD, Boston Children's Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 31, 2011
Primary Completion (Anticipated)
November 30, 2020
Study Completion (Anticipated)
November 30, 2020
Study Registration Dates
First Submitted
August 31, 2011
First Submitted That Met QC Criteria
March 8, 2012
First Posted (Estimate)
March 13, 2012
Study Record Updates
Last Update Posted (Actual)
April 21, 2020
Last Update Submitted That Met QC Criteria
April 19, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P00000440
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anger
-
Ege UniversityCompleted
-
naomi goldsteinNational Institute of Mental Health (NIMH)Completed
-
Walter Reed Army Institute of Research (WRAIR)Enrolling by invitation
-
Örebro University, SwedenKarolinska InstitutetCompletedMaladaptive Anger InhibitionSweden
-
Karolinska InstitutetCompletedInappropriate Anger ExpressionSweden
-
Florida State UniversityCompletedAnger | Smoking CessationUnited States
-
University of Colorado, DenverChildrens Hospital ColoradoRecruitingAnger | Irritable Mood | Temper TantrumUnited States
-
VA Office of Research and DevelopmentCompleted
-
Kafkas UniversityCompleted
-
Mersin UniversityCompletedAnger Problems | Spiritual Well-beingTurkey (Türkiye)
Clinical Trials on ACT
-
Idorsia Pharmaceuticals Ltd.Completed
-
Idorsia Pharmaceuticals Ltd.CompletedHealthy SubjectsNetherlands
-
Azusa Pacific UniversityWithdrawnAnxiety Disorders | Stress Disorders, Traumatic | AnxietyUnited States
-
Idorsia Pharmaceuticals Ltd.Terminated
-
Idorsia Pharmaceuticals Ltd.CompletedPharmacokinetics | Pharmacodynamics | Tolerability | SafetyNetherlands
-
Karolinska InstitutetRegion Stockholm; Forte; Stiftelsen Frimurarna BarnhusetActive, not recruitingDepression | Stress, Psychological | Intellectual Disability | Anxiety | Neurodevelopmental Disorders | Traumatic Brain Injury | Autism Spectrum Disorder | Parents | Attention Deficit Hyperactivity Disorder | Physical DisabilitySweden
-
University of CoimbraFundação para a Ciência e a TecnologiaUnknown
-
University College DublinCompletedInflammatory Bowel DiseaseIreland
-
Universidad del Valle, ColombiaCompletedEmotional Distress | Psychological Flexibility | Psychological Well-Being | Experiential Avoidance | Cognitive FusionColombia